Olof Andries Blokzijl

Moleculink AB provides diagnostic products for life science research purposes. The firm provides products and services for human protein biomarker research and development. It offers analysis service for comprehensive protein biomarker analyses based on Proseek Multiplex. The company was founded by Dag Åke Ulf Landegren, Björn Lennart Ekström, Mårten Winge, Johan Erik Simon Fredriksson, Jonas Sven Peter Jarvius, Bernitz Mats Bo Johan Nilsson, and Mats Gullberg in 2004 and is headquartered in Uppsala, Sweden.

Beijer Ventures AB (Beijer Ventures) a venture capital subsidiary of Beijer Holding AB founded in 2000. The firm is headquartered in Stockholm, Sweden.

Doktorse Nordic AB provides healthcare services. It offers digital and physical health centers, dedicated nurses, specialist nurses, doctors, specialists, psychologists, curators, and physiotherapists. The company was founded by Martin Lindman and Svante Tegner in 2016 and is headquartered in Stockholm, Sweden.

Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden.

Aleris Healthcare AB provides health and specialty care. The company is headquartered in Stockholm, Sweden.

Part of Roche Holding AG, Roche AB is a biotechnology company founded in 1896. The company is based in Solna, Sweden and creates innovative treatments to help millions of patients worldwide. Roche actively seeks partnerships with healthcare providers, academia, patient associations, organizations, external companies, and startups to identify needs that form the basis for collaborations. Roche is one of the world's largest research-based biotechnology companies, focusing on advancing science to improve people's lives. The Swedish company develops both drugs and diagnostics and has great respect for the multiple perspectives required to create tomorrow's healthcare.

ExScale Biospecimen Solutions AB provides automated, next generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded tissue sections using paramagnetic beads. It specializes in processes and know-how for nucleic acid extraction from human tissue specimens. The firm's technology enables serial extraction of DNA and RNA from the same bio-specimen where the isolated nucleic acids are of optimal quality for next generation sequencing and other downstream applications. It offers ExScale NGEx kit which consists of plastic-ware, reagents packed into prefilled cartridges and a deparaffinisation reagent. The company was founded by Lucy Mathot and Carl Tobias Sjöblom in 2012 and is headquartered in Uppsala, Sweden.

Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden.

Neogap Therapeutics AB is a Swedish clinical stage biopharmaceutical company. The private company is based in Stockholm, Sweden.

Pelago Bioscience AB is a specialized CRO that focuses on their patented cetsa® technology. The private company is based in Solna, Sweden. The technology can be applied throughout all steps of the drug discovery value chain. Pelago Bioscience provides bespoke projects in a wide range of services. The Swedish company's cetsa® navigate enables rapid target engagement confirmation, cetsa® navigate ht is for efficient high-throughput discovery, and cetsa® explore is a mass spectrometry-based approach allowing unbiased proteome-wide investigation. The Pelago Knowledge Center is a collection of resources used to drive innovation in drug discovery focusing on excellence in target engagement.

AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.

Part of Pfizer Inc., Pharmacia AB /Hillerod Unit/ is a pharmaceutical company based in Hillerod, Sweden. Pharmacia AB /Hillerod Unit was acquired by Pharmacia AB /Hillerod UnitManagement/ on January 10, 2001.

SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden.

Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden.

Balticgruppen Bio AB is a Swedish biopharmaceutical company that develops activated protein kinase. The company was founded by Olof Karlsson, Thomas Edlund, and Helena Edlund. Thomas Edlund has been the CEO since incorporation.

Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden.

CartaNA AB engages in research and development of disease diagnostics, cellular and molecular biology. The company was founded by Malte Kühnemund, Francesca Bignami and Xiaoyan Qian and is headquartered in Solna, Sweden.

Pixelgen Technologies AB is a company that was founded in 2020 by a team of experienced innovators and entrepreneurs. The company is based in Solna, Sweden. Pixelgen has developed a DNA-based visualization technology called molecular pixelation, which analyzes cell surface proteins to gain insights into cellular activity. The Swedish company aims to deepen the understanding of biology for a healthier world with their technology. Pixelgen's products are covered by one or more claims of patents or pending patent applications. The company was founded by Johan Erik Simon Fredriksson, Alvaro Martinez Barrio, Filip Karlsson, and Fredrik Dahl, with Johan Erik Simon Fredriksson serving as the CEO since 2020.

Halo Genomics AB operates as a genomics company. It offers sample preparation solutions to provide scientists with enabling tools to analyze the genetic foundation of disease. The firm provides reagent kits and a service for the multiplex amplification of exons for targeted re-sequencing that includes selector probe library design and synthesis, target regions amplification, and quality control of the enrichment. The company was founded by Olle Ericsson in 2008 and is headquartered in Uppsala, Sweden.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.

Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden.